Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Revenue 2020–2025
Fulcrum Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fulcrum Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0.
- Fulcrum Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 80.0 M, a 4036.50% increase year-over-year.
- Fulcrum Therapeutics Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Fulcrum Therapeutics Inc. annual revenue for 2024 was 80.0 M, a 2752.05% increase from 2023.
- Fulcrum Therapeutics Inc. annual revenue for 2023 was 2.8 M, a 55.77% decrease from 2022.
- Fulcrum Therapeutics Inc. annual revenue for 2022 was 6.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fulcrum Therapeutics Inc. (FULC) — Frequently Asked Questions
Fulcrum Therapeutics Inc. (FULC) is a publicly traded US company. It has a market capitalization of $222,376.05. Explore FULC's stock price, financial statements, earnings history, margins and key ratios below.
What is Fulcrum Therapeutics Inc.'s market cap?
Fulcrum Therapeutics Inc. (FULC) has a market capitalization of $222,376.05.
What is the FULC stock price?
FULC trades at $3.51 (-0.28% on the day).
Is FULC profitable?
In fiscal 2025, Fulcrum Therapeutics Inc. reported net income of -$75M.